Article Text
Statistics from Altmetric.com
- confidentiality/privacy
- genetic Screening/testing
- genetic information
- legal philosophy
- predictive genetic testing
I am grateful to the respondents (and the journal editors) for the opportunity provided, to clarify the concept of a libertarian right to test (LRT in what follows) and its normative implications. To sum up, I concede that genomes have a normatively salient informational aspect, that exercising the LRT may cause informational harm and violate rights of genetically related individuals, and that this is relevant to the regulation of genetic testing. But such considerations are logically compatible with a non-absolute LRT and its libertarian justification. The LRT is practically relevant because it inverts the burden of justification and recognising a LRT may affect the way in which other rights are protected in a conflict of rights case. I will try to clarify this further, in what follows.
Consider B, an individual who is, and is aware of being, genetically related to A. Admittedly, while person A has a LRT, the interests of person B should also be protected.1 …
Footnotes
Contributors ML is the sole author of this manuscript and individually responsible for the content in it.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
Correction notice This article has been corrected since it was published Online First, to fix an encoding error in the corresponding author’s address.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Direct to consumer genetic testing and the libertarian right to test
- Are pharmaceutical patents protected by human rights?
- Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
- Intellectual property rights and detached human body parts
- Sport and exercise genomics: the FIMS 2019 consensus statement update
- Containing diffusion: the tobacco industry’s multipronged trade strategy to block tobacco standardised packaging
- Don’t worry about the drug industry’s profits when considering a waiver on covid-19 intellectual property rights
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine
- Yours, mine, or ours: cautions about LRT
- The argument for property rights in body parts: scarcity of resources